Cell Therapy Bioreactors Global Market Report 2026

Cell therapy bioreactors are advanced systems engineered to support the controlled growth, expansion, and differentiation of cells for therapeutic purposes. They offer a regulated environment with precise control over parameters such as temperature, pH, oxygen, and nutrient supply to ensure cell viability and functionality. By allowing scalable and reproducible cell production, these bioreactors support the development and manufacturing of sophisticated cell-based therapies.

The main products in cell-therapy bioreactors include stirred-tank bioreactors, wave-induced bioreactors, fixed-bed bioreactors, and others. Stirred-tank systems agitate cultures for uniform growth, while wave-induced systems mix gently using rocking motion. Cell types include stem cells, immune cells, differentiated cells, and others. Systems may be single-use or reusable. Applications span research, clinical studies, and commercial manufacturing, serving pharmaceutical companies, research institutes, CMOs, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have influenced the cell therapy bioreactor market by increasing the cost of imported bioreactor components and culture media, impacting production timelines and supply chain efficiency. high tariffs particularly affect single-use and advanced automated systems imported into regions such as north america and europe. stem cell and immune cell production segments face significant cost pressures, while local manufacturing initiatives may benefit from increased domestic demand. overall, tariffs encourage innovation in cost-effective manufacturing solutions while presenting challenges for global suppliers.

The cell therapy bioreactors market research report is one of a series of new reports from The Business Research Company that provides cell therapy bioreactors market statistics, including cell therapy bioreactors industry global market size, regional shares, competitors with a cell therapy bioreactors market share, detailed cell therapy bioreactors market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy bioreactors industry. This cell therapy bioreactors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell therapy bioreactors market size has grown rapidly in recent years. It will grow from $1.24 billion in 2025 to $1.44 billion in 2026 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to increasing demand for cell-based therapies, growing investment in regenerative medicine, rising adoption of automated cell culture systems, expansion of stem cell research, and increasing need for scalable cell production.

The cell therapy bioreactors market size is expected to see rapid growth in the next few years. It will grow to $2.61 billion in 2030 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to growing adoption of cell therapy bioreactors in manufacturing, rising investment in advanced bioprocessing technologies, increasing focus on process optimization and quality control, expansion of clinical trials involving cell therapies, and growing demand for personalized medicine applications. Major trends in the forecast period include advancements in automated cell culture technologies, innovations in bioreactor design for enhanced scalability, developments in stem cell expansion platforms, research and development in process monitoring and control systems, and emerging upgrades in integrated cell therapy manufacturing solutions.

The growing demand for gene therapies is expected to propel the growth of the cell therapy bioreactors market going forward. Gene therapy refers to a medical technique that involves modifying or replacing defective genes to treat or prevent diseases. The increasing demand for gene therapy is due to advancements in genetic sequencing and diagnostics, which enable precise identification of disease-causing genes for targeted treatment. Cell therapy bioreactors accelerate gene therapies by providing optimized environments for the growth, modification, and expansion of therapeutic cells. They enhance treatment development and scalability by ensuring consistent cell quality, improving efficiency, and supporting faster production of personalized gene-based therapies. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved 6 gene therapy products in 2023, up from 5 approvals in 2022. Therefore, the growing demand for gene therapies is driving the growth of the cell therapy bioreactors market.

The rising prevalence of chronic diseases is anticipated to drive the growth of the cell therapy bioreactors sector in the coming years. Chronic and rare diseases encompass long-term health conditions and uncommon disorders that often necessitate specialized treatment strategies, including personalized and regenerative therapies. The increase in chronic diseases is largely attributed to unhealthy lifestyles, such as poor diet, physical inactivity, and smoking, which elevate the risk of ailments like diabetes, heart disease, and obesity. Cell therapy bioreactors aid in managing chronic diseases by providing controlled environments for the cultivation and expansion of therapeutic cells. They improve treatment efficacy and scalability by maintaining consistent cell quality, facilitating personalized therapies, and supporting long-term patient care. For example, in 2025, the International Diabetes Federation, a Belgium-based health organization, reported that approximately 589 million adults aged 20-79 were living with diabetes in 2024, with the total expected to rise to 853 million by 2050. Consequently, the growing prevalence of chronic and rare diseases is fueling the expansion of the cell therapy bioreactors sector.

Major companies operating in the cell therapy bioreactors sector are concentrating on developing advanced platforms, such as modular, multi-scale bioreactor systems, to enhance process scalability, cell expansion efficiency, and consistency from early research to commercial production. A modular multi-scale bioreactor system is a versatile setup that allows researchers to perform parallel small-scale experiments, optimize conditions, and seamlessly scale up to mid- or large-scale production while maintaining uniform culture conditions and high yields. For example, in July 2024, EXO-Harvest, a Belgium-based biomanufacturing technology firm, introduced its state-of-the-art multi-scale bioreactor platform for efficient production of mesenchymal stem cells and extracellular vesicles, supporting scalable adherent cell culture from discovery to industrial manufacturing. The platform comprises small-scale multi-bioreactor screening and mid/large-scale systems designed to accelerate development, reduce costs, and deliver high-quality cultures with precise environmental control.

Major companies operating in the cell therapy bioreactors market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Holdings Corporation, Danaher Corporation, Corning Incorporated, Lonza Group, Terumo Corporation, Sartorius AG, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, PBS Biotech Inc., Meissner Filtration Products Inc., Infors AG, Bionet Engineering & Technologies Pvt. Ltd., Wilson Wolf Manufacturing Corporation, Synthecon Incorporated, Cellexus Limited, Celartia Inc., Able Biott Inc., CelVivo ApS

North America was the largest region in the cell therapy bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy bioreactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell therapy bioreactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell therapy bioreactors market consists of sales of bioreactor vessels, control systems, single-use bioreactor units, perfusion bioreactors, and monitoring and automation equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Therapy Bioreactors Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cell therapy bioreactors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell therapy bioreactors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell therapy bioreactors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Stirred Tank Bioreactors; Wave-Induced Bioreactors; Fixed-Bed Bioreactors; Other Products
• 2) By Cell Type: Stem Cells; Immune Cells; Differentiated Cells; Other Cell Types
• 3) By Material: Single-Use Bioreactors; Reusable Bioreactors
• 4) By Application: Research; Clinical; Commercial Production
• 5) By End-Users: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Manufacturing Organizations (CMOs); Other End Users
• Subsegments:
• 1) By Stirred Tank Bioreactors: Stainless Steel Stirred Tank Systems; Glass Stirred Tank Systems; Single Use Stirred Tank Systems; Automated Stirred Tank Systems
• 2) By Wave Induced Bioreactors: Rocking Motion Bioreactor Systems; Single Use Wave Bag Systems; Modular Wave Platform Systems; Automated Wave Based Culture Systems
• 3) By Fixed Bed Bioreactors: Packed Bed Bioreactor Systems; Scaffold Based Fixed Bed Systems; Microcarrier Based Fixed Bed Systems; Perfusion Enabled Fixed Bed Systems
• 4) By Other Products: Hollow Fiber Bioreactor Systems; Perfusion Bioreactor Systems; Rotary Cell Culture Systems; Microfluidic Bioreactor Systems
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; FUJIFILM Holdings Corporation; Danaher Corporation; Corning Incorporated; Lonza Group; Terumo Corporation; Sartorius AG; Eppendorf AG; Miltenyi Biotec B.V. & Co. KG; PBS Biotech Inc.; Meissner Filtration Products Inc.; Infors AG; Bionet Engineering & Technologies Pvt. Ltd.; Wilson Wolf Manufacturing Corporation; Synthecon Incorporated; Cellexus Limited; Celartia Inc.; Able Biott Inc.; CelVivo ApS
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.